Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Hernández, Daniel Alberto"'
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Publikováno v:
Revue Anthropologie et Sociétés; 2022, Vol. 46 Issue 3, p270-272, 4p
Autor:
Hernández, Daniel Alberto
Publikováno v:
Vidaillet H, Granada JF, Chyou et al. A population-based study of mortality among patients with atrial fibrillation or flutter. Am J Med 2002; 113: 365-70.
Wolf P, D’Agostino R, Belanger A et al. Probality of stroke: a risk profile from the Framingham study. Stroke 1991; 22: 312-8.
Wolf P, Dawber T, Thomas H et al. Epidemiologic assessment of chronic atrial fibrillation and risk of stroke: the Framingham study. Neurology 1978; 28: 973-7.
Dickson BC. Venous thrombosis: on the history of Virchow´s triad. Univ Toronto Med J. 2004; 81:166.
B, Guenoun M, Hohnloser SH, Kolh P, Lip GY, Manolis A, McMurray J, Ponikowski P, Rosenhek R, Ruschitzka F, Savelieva I, Sharma S, Suwalski P, Tamargo JL, Taylor CJ, Van Gelder IC, Voors AA, Windecker S, Zamorano JL, Zeppenfeld K. 2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS. Eur Heart J 2016;37:2893–2962.
Nutescu EA. The future of anticoagulation clinics. J Thrombosis and Thrombolysis 2003; 16 (1/2): 61-63.
Chiquette E, Amanto MG, Bussey HI. Comparison of an anticoagulation clinics with usual medical care anticoagulation control, patient outcomes and health care cost. Arch Intern Med 1998; 158: 1641-1647.
Anseel JE, Hughes RM. Involving models of warfarin management: anticoagulation clinics, patient selfmonitoring and patients self-management. Am Heart J 1996; 1095-1100.
Hirsh J, Dalen JE, Anderson DR, et al. Oral anticoagulants: mechanism of action, clinical effectiveness and optimal therapeutic range. Sixth ACCP. Consensus Conference on Antithrombotic Therapy. Chest 2001; 119 (1) (suppl): 8S-21S.
Geoffrey D. Barnes, MD, MSc1, Brahmajee K. Nallamothu, MD, MPH1, Anne E. Sales, PhD, RN2, and James B. Froehlich, MD, MPH. Reimagining Anticoagulation Clinics in the Era of Direct Oral Anticoagulants. Circ Cardiovasc Qual Outcomes. 2016 March ; 9(2): 182–185.
Ocampo C, Hernández O, Velásquez C, Tobón I, Mejía F. La clínica de anticoagulación del Hospital Universitario San Vicente de Paúl: demografía, efectividad y complicaciones. Iatreia.2004;17(2):105---14.
Taboada LB, Silva LE, Montenegro AC. Beneficios de la clínica de anticoagulación. Acta Med Colomb. 2013;38:239---43.
Ligia P. Laverde, Sonia E. Gómez, Ana C. Montenegro, Alberto Lineros, Beatriz Wills y Andrés F. Buitrago. Experiencia de una clínica de anticoagulación. Rev Colomb Cardiol. 2015;22(5):224---230.
Hua Cao, Jianmei Wu, Jinhua Zhang. Outcomes of warfarin therapy managed by pharmacists via hospital anticoagulation clinic versus online anticoagulation clinic. International Journal of Clinical Pharmacy. 2018 Oct;40(5): 1072-1077.
Kaatz S. Determinants and measures of quality in oral anticoagulation therapy. J Thromb Thrombolysis. 2008 Feb;25(1):61-6. Epub 2007 Sep 29
Corey S. Miller, BA, Sonia M Grandi, Avi Shimony, et al. Meta-Analysis of Efficacy and Safety of New Oral Anticoagulants (Dabigatran, Rivaroxaban, Apixaban) Versus Warfarin in Patients With Atrial Fibrilation. Am J Cardiol 2012;110:453-460
van Walraven C, Jennings A, Oake N, et al. Effect of study setting on anticoagulation control: a systematic review and metaregression. Chest 2006; 129:1155.
Pisters Pisters R, Lane DA, Nieuwlaat R, de Vos CB, Crijns HJ, Lip GY. A novel user-friendly score (HAS-BLED) to assess 1-year risk of major bleeding in patients with atrial fibrillation: the Euro Heart Survey. Chest. 2010 Nov;138(5):1093-100. doi: 10.1378/chest.10-0134. Epub 2010 Mar 18.
Wolf P, D’Agostino R, Belanger A et al. Probality of stroke: a risk profile from the Framingham study. Stroke 1991; 22: 312-8.
Wolf P, Dawber T, Thomas H et al. Epidemiologic assessment of chronic atrial fibrillation and risk of stroke: the Framingham study. Neurology 1978; 28: 973-7.
Dickson BC. Venous thrombosis: on the history of Virchow´s triad. Univ Toronto Med J. 2004; 81:166.
B, Guenoun M, Hohnloser SH, Kolh P, Lip GY, Manolis A, McMurray J, Ponikowski P, Rosenhek R, Ruschitzka F, Savelieva I, Sharma S, Suwalski P, Tamargo JL, Taylor CJ, Van Gelder IC, Voors AA, Windecker S, Zamorano JL, Zeppenfeld K. 2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS. Eur Heart J 2016;37:2893–2962.
Nutescu EA. The future of anticoagulation clinics. J Thrombosis and Thrombolysis 2003; 16 (1/2): 61-63.
Chiquette E, Amanto MG, Bussey HI. Comparison of an anticoagulation clinics with usual medical care anticoagulation control, patient outcomes and health care cost. Arch Intern Med 1998; 158: 1641-1647.
Anseel JE, Hughes RM. Involving models of warfarin management: anticoagulation clinics, patient selfmonitoring and patients self-management. Am Heart J 1996; 1095-1100.
Hirsh J, Dalen JE, Anderson DR, et al. Oral anticoagulants: mechanism of action, clinical effectiveness and optimal therapeutic range. Sixth ACCP. Consensus Conference on Antithrombotic Therapy. Chest 2001; 119 (1) (suppl): 8S-21S.
Geoffrey D. Barnes, MD, MSc1, Brahmajee K. Nallamothu, MD, MPH1, Anne E. Sales, PhD, RN2, and James B. Froehlich, MD, MPH. Reimagining Anticoagulation Clinics in the Era of Direct Oral Anticoagulants. Circ Cardiovasc Qual Outcomes. 2016 March ; 9(2): 182–185.
Ocampo C, Hernández O, Velásquez C, Tobón I, Mejía F. La clínica de anticoagulación del Hospital Universitario San Vicente de Paúl: demografía, efectividad y complicaciones. Iatreia.2004;17(2):105---14.
Taboada LB, Silva LE, Montenegro AC. Beneficios de la clínica de anticoagulación. Acta Med Colomb. 2013;38:239---43.
Ligia P. Laverde, Sonia E. Gómez, Ana C. Montenegro, Alberto Lineros, Beatriz Wills y Andrés F. Buitrago. Experiencia de una clínica de anticoagulación. Rev Colomb Cardiol. 2015;22(5):224---230.
Hua Cao, Jianmei Wu, Jinhua Zhang. Outcomes of warfarin therapy managed by pharmacists via hospital anticoagulation clinic versus online anticoagulation clinic. International Journal of Clinical Pharmacy. 2018 Oct;40(5): 1072-1077.
Kaatz S. Determinants and measures of quality in oral anticoagulation therapy. J Thromb Thrombolysis. 2008 Feb;25(1):61-6. Epub 2007 Sep 29
Corey S. Miller, BA, Sonia M Grandi, Avi Shimony, et al. Meta-Analysis of Efficacy and Safety of New Oral Anticoagulants (Dabigatran, Rivaroxaban, Apixaban) Versus Warfarin in Patients With Atrial Fibrilation. Am J Cardiol 2012;110:453-460
van Walraven C, Jennings A, Oake N, et al. Effect of study setting on anticoagulation control: a systematic review and metaregression. Chest 2006; 129:1155.
Pisters Pisters R, Lane DA, Nieuwlaat R, de Vos CB, Crijns HJ, Lip GY. A novel user-friendly score (HAS-BLED) to assess 1-year risk of major bleeding in patients with atrial fibrillation: the Euro Heart Survey. Chest. 2010 Nov;138(5):1093-100. doi: 10.1378/chest.10-0134. Epub 2010 Mar 18.
Objetivo: Describir las características clínicas y eventos de sangrado de la población atendida por la clínica de anticoagulación en el Hospital Militar Central, discriminando por ocurrencia de sangrado y documentando los indicadores habituales
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______2802::24cce76a461d3668e28ed045178a27be
https://hdl.handle.net/10654/34920
https://hdl.handle.net/10654/34920
Ce travail propose comme objectif d'explorer anthropologiquement la rencontre entre le chercheur et les rapports complexes qui sont constitués par les rituels d'ingestion du yajé, guidés par les taitas kofanes dans le contexte d'un « tour » tour
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::9bce4ec8a7d87bb0e15f13787ad53404
Publikováno v:
Revue Anthropologie et Sociétés; 2022, Vol. 46 Issue 2, p214-215, 2p